NeuroPace Balance Sheet Health
Financial Health criteria checks 5/6
NeuroPace has a total shareholder equity of $9.8M and total debt of $59.3M, which brings its debt-to-equity ratio to 603.3%. Its total assets and total liabilities are $96.3M and $86.5M respectively.
Key information
603.3%
Debt to equity ratio
US$59.27m
Debt
| Interest coverage ratio | n/a |
| Cash | US$56.83m |
| Equity | US$9.82m |
| Total liabilities | US$86.48m |
| Total assets | US$96.30m |
Recent financial health updates
Does NeuroPace (NASDAQ:NPCE) Have A Healthy Balance Sheet?
Nov 07
Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?
Apr 12Recent updates
After Leaping 90% NeuroPace, Inc. (NASDAQ:NPCE) Shares Are Not Flying Under The Radar
Dec 04Here's What Analysts Are Forecasting For NeuroPace, Inc. (NASDAQ:NPCE) After Its Third-Quarter Results
Nov 14Does NeuroPace (NASDAQ:NPCE) Have A Healthy Balance Sheet?
Nov 07NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch
Aug 03Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?
Apr 12NeuroPace: Picking Up The Pace
Feb 25Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge
Jan 22NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company
Apr 17NeuroPace announces U.S. distribution agreement with DIXI Medical
Aug 11NeuroPace EPS misses by $32.45, beats on revenue; issues guidance
Jun 03Financial Position Analysis
Short Term Liabilities: NPCE's short term assets ($82.6M) exceed its short term liabilities ($14.8M).
Long Term Liabilities: NPCE's short term assets ($82.6M) exceed its long term liabilities ($71.7M).
Debt to Equity History and Analysis
Debt Level: NPCE's net debt to equity ratio (24.8%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if NPCE's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NPCE has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: NPCE has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 3.6% each year
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 08:52 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NeuroPace, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| Ross Osborn | Cantor Fitzgerald & Co. |
| Robert Marcus | J.P. Morgan |